• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROSA SYS W/ADJ.DP.UNIT A.CONTROL RES.; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROSA SYS W/ADJ.DP.UNIT A.CONTROL RES.; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV770T
Device Problem Infusion or Flow Problem (2964)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 02/17/2020
Event Type  Injury  
Manufacturer Narrative
When additional information becomes available a follow up report will be submitted.
 
Event Description
It was reported that there is an issue with valve.The reporter indicated that a 3 year 4 day post-operative valve has a blockage and a dysfunction.The device was explanted.Additional event details and has not provided, however, have been requested.
 
Manufacturer Narrative
Investigation: visual inspection: in the first step of our investigations a visual inspection is performed.It is tested whether any defects, deformations or other abnormalities are to be detected.Permeability test: to proof the penetrability of the valve we have carried out a penetrability test.This test is carried out at a hydrostatic pressure of approximately 30 cmh2o + 11 cmh2o in the horizontal flow direction.Computer controlled test: the test is performed with a miethke computer controlled testing apparatus.The progav was tested by simulating a cerebrospinal fluid flow at rates between 60 ml/h down to 5 ml/h in the horizontal and vertical position (in acc.To iso 7197).Distilled water is used as test-liquid.Adjustment test: the adjustment test is used to examine whether progav valve can be adjusted in all pressure levels.The attempt is made to move the valve up and down in steps of 5cmh2o in the corresponding pressure range.Braking force and brake function test: to measure the braking force, we tested the progav valve with a braking force apparatus.Here it is measured how much force must be exerted on the housing to release the rotor to adjust the valve by the integrated magnet of the braking force apparatus.Results: first, we performed a visual inspection of the progav.No significant deformations or damage of the valve were detected during the visual inspection.Also the measurement of parallelism was within the accepted tolerance (tol.0 ± 0,02 mm).In the next step the valve could be tested positively for permeability.In order to investigate the suspicion of a malfunction, we carried out a computer-controlled measurement on the progav valve.The progav valve was measured at an opening pressure of 11 cmh20 in a horizontal position.With a measured value of 8,20 cmh20 in the reference flow level of 20 ml/h the valve operates within the accepted tolerance.Additionally, we tested the adjustability as well as the brake functionality and brake force of the progav valve.The valve was adjustable to all settings.The braking force and brake function were also within tolerance.Finally, we have dismantled the valve.Inside the valve, we have found visible build-up of substances (likely protein).Based on our investigation, we are unable to substantiate the claim of occlusion and malfunction.At the time of our investigation, the valve met all test criteria.Nevertheless, we suspect that the deposits found inside the valve could have led to the functional impairment in the past.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROSA SYS W/ADJ.DP.UNIT A.CONTROL RES.
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key9843176
MDR Text Key183758421
Report Number3004721439-2020-00058
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K120559
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/29/2021
Device Model NumberFV770T
Device Catalogue NumberFV770T
Device Lot Number20032006
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/24/2020
Date Manufacturer Received03/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age24 YR
Patient Weight100
-
-